Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perfect

Showing results (321-330 of 673) with videos related to

Pageof 68
Sort By:
Infection Control and Hospital Epidemiology|December 1, 1993
Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated casesC W Ingram, H B Haywood, V M Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformansJ K Lodge, E Jackson-Machelski, D L Toffaletti, et al.
Journal of Fungi (Basel, Switzerland)|August 28, 2024
Efficacy of Liposomal Nystatin in a Rabbit Model of Cryptococcal MeningitisCharles D Giamberardino, Wiley A Schell, Jennifer L Tenor, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study GroupR H Drew, J R Perfect, L Srinath, et al.
Journal of Bacteriology|March 1, 1993
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNAD L Toffaletti, T H Rude, S A Johnston, et al.
Cancer Medicine|March 20, 2014
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort studyHsiang-Chi Kung, Melissa D Johnson, Richard H Drew, et al.
Plos One|September 13, 2012
The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistanceRebecca S Shapiro, Aimee K Zaas, Marisol Betancourt-Quiroz, et al.
Plos One|December 27, 2007
Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanismsSteven S Giles, Aimee K Zaas, Mike F Reidy, et al.
Expert Opinion on Pharmacotherapy|September 21, 2013
Recent advances in the treatment of life-threatening, invasive fungal infectionsRichard H Drew, Mary L Townsend, Melanie W Pound, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow supportC Gilbert, B Meisenberg, J Vredenburgh, et al.
Pageof 68

Showing results (321-330 of 673) with videos related to

Sort By:
Pageof 68
Infection Control and Hospital Epidemiology|December 1, 1993
Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated casesC W Ingram, H B Haywood, V M Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformansJ K Lodge, E Jackson-Machelski, D L Toffaletti, et al.
Journal of Fungi (Basel, Switzerland)|August 28, 2024
Efficacy of Liposomal Nystatin in a Rabbit Model of Cryptococcal MeningitisCharles D Giamberardino, Wiley A Schell, Jennifer L Tenor, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study GroupR H Drew, J R Perfect, L Srinath, et al.
Journal of Bacteriology|March 1, 1993
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNAD L Toffaletti, T H Rude, S A Johnston, et al.
Cancer Medicine|March 20, 2014
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort studyHsiang-Chi Kung, Melissa D Johnson, Richard H Drew, et al.
Plos One|September 13, 2012
The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistanceRebecca S Shapiro, Aimee K Zaas, Marisol Betancourt-Quiroz, et al.
Plos One|December 27, 2007
Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanismsSteven S Giles, Aimee K Zaas, Mike F Reidy, et al.
Expert Opinion on Pharmacotherapy|September 21, 2013
Recent advances in the treatment of life-threatening, invasive fungal infectionsRichard H Drew, Mary L Townsend, Melanie W Pound, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow supportC Gilbert, B Meisenberg, J Vredenburgh, et al.
Pageof 68